Merck Historical Income Statement

MRK Stock  USD 131.75  6.23  4.96%   
Historical analysis of Merck income statement accounts such as Gross Profit of 46.1 B can show how well Merck Company performed in making a profits. Evaluating Merck income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Merck's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Merck Company latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Merck Income Statement Analysis

Merck Company Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Merck shareholders. The income statement also shows Merck investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Merck Income Statement Chart

Merck Company Income Statement is one of the three primary financial statements used for reporting Merck's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merck Company revenue and expense. Merck Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Merck's Total Operating Expenses is quite stable compared to the past year. Income Tax Expense is expected to rise to about 2 B this year, although the value of Operating Income will most likely fall to about 2.8 B.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Merck Company minus its cost of goods sold. It is profit before Merck operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Merck Company. It is also known as Merck overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Merck Company operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Merck Company is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most accounts from Merck's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At this time, Merck's Total Operating Expenses is quite stable compared to the past year. Income Tax Expense is expected to rise to about 2 B this year, although the value of Operating Income will most likely fall to about 2.8 B.
 2021 2022 2023 2024 (projected)
Gross Profit35.1B41.9B43.9B46.1B
Total Revenue48.7B59.3B59.9B32.5B

Merck income statement Correlations

0.210.470.130.240.41-0.090.350.760.040.280.020.20.28-0.240.93-0.26-0.470.14-0.310.49-0.290.050.50.52-0.48
0.210.760.970.960.230.340.410.680.920.14-0.030.110.20.80.42-0.36-0.21-0.68-0.69-0.620.41-0.15-0.58-0.590.49
0.470.760.780.690.620.430.610.90.550.480.10.480.180.370.56-0.21-0.15-0.52-0.65-0.420.220.0-0.43-0.270.38
0.130.970.780.950.320.40.440.650.910.19-0.040.20.110.810.35-0.24-0.07-0.73-0.69-0.660.38-0.02-0.68-0.660.56
0.240.960.690.950.090.20.30.650.970.01-0.06-0.020.160.860.48-0.34-0.25-0.63-0.63-0.510.34-0.12-0.51-0.540.43
0.410.230.620.320.090.590.730.6-0.080.760.140.80.14-0.260.310.080.22-0.19-0.4-0.13-0.040.41-0.170.00.08
-0.090.340.430.40.20.590.90.330.130.870.710.850.460.09-0.120.050.69-0.410.1-0.480.070.33-0.55-0.430.42
0.350.410.610.440.30.730.90.640.140.940.680.890.56-0.020.29-0.060.45-0.32-0.05-0.24-0.060.33-0.3-0.180.18
0.760.680.90.650.650.60.330.640.450.50.160.470.290.190.79-0.32-0.26-0.33-0.57-0.13-0.010.01-0.15-0.030.12
0.040.920.550.910.97-0.080.130.140.45-0.15-0.13-0.170.090.960.31-0.29-0.22-0.65-0.56-0.570.43-0.16-0.57-0.630.48
0.280.140.480.190.010.760.870.940.5-0.150.730.970.51-0.290.160.10.51-0.180.09-0.15-0.140.34-0.22-0.080.17
0.02-0.030.1-0.04-0.060.140.710.680.16-0.130.730.630.65-0.16-0.040.080.57-0.010.6-0.08-0.140.15-0.15-0.110.18
0.20.110.480.2-0.020.80.850.890.47-0.170.970.630.28-0.30.070.220.58-0.160.03-0.22-0.250.44-0.31-0.170.25
0.280.20.180.110.160.140.460.560.290.090.510.650.280.00.3-0.27-0.01-0.20.240.060.36-0.140.160.16-0.13
-0.240.80.370.810.86-0.260.09-0.020.190.96-0.29-0.16-0.30.00.05-0.22-0.11-0.64-0.43-0.630.48-0.17-0.63-0.70.53
0.930.420.560.350.480.31-0.120.290.790.310.16-0.040.070.30.05-0.33-0.550.0-0.420.31-0.09-0.090.360.34-0.31
-0.26-0.36-0.21-0.24-0.340.080.05-0.06-0.32-0.290.10.080.22-0.27-0.22-0.330.380.30.270.08-0.240.72-0.12-0.20.04
-0.47-0.21-0.15-0.07-0.250.220.690.45-0.26-0.220.510.570.58-0.01-0.11-0.550.380.040.53-0.22-0.270.56-0.43-0.350.28
0.14-0.68-0.52-0.73-0.63-0.19-0.41-0.32-0.33-0.65-0.18-0.01-0.16-0.2-0.640.00.30.040.530.72-0.440.210.620.57-0.57
-0.31-0.69-0.65-0.69-0.63-0.40.1-0.05-0.57-0.560.090.60.030.24-0.43-0.420.270.530.530.38-0.290.170.30.27-0.27
0.49-0.62-0.42-0.66-0.51-0.13-0.48-0.24-0.13-0.57-0.15-0.08-0.220.06-0.630.310.08-0.220.720.38-0.470.190.870.83-0.91
-0.290.410.220.380.34-0.040.07-0.06-0.010.43-0.14-0.14-0.250.360.48-0.09-0.24-0.27-0.44-0.29-0.47-0.36-0.29-0.260.32
0.05-0.150.0-0.02-0.120.410.330.330.01-0.160.340.150.44-0.14-0.17-0.090.720.560.210.170.19-0.36-0.09-0.09-0.17
0.5-0.58-0.43-0.68-0.51-0.17-0.55-0.3-0.15-0.57-0.22-0.15-0.310.16-0.630.36-0.12-0.430.620.30.87-0.29-0.090.92-0.9
0.52-0.59-0.27-0.66-0.540.0-0.43-0.18-0.03-0.63-0.08-0.11-0.170.16-0.70.34-0.2-0.350.570.270.83-0.26-0.090.92-0.84
-0.480.490.380.560.430.080.420.180.120.480.170.180.25-0.130.53-0.310.040.28-0.57-0.27-0.910.32-0.17-0.9-0.84
Click cells to compare fundamentals

Merck Account Relationship Matchups

Merck income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization3.7B3.6B3.2B3.9B3.9B2.8B
Interest Expense893M831M806M962M1.1B1.2B
Total Revenue46.8B48.0B48.7B59.3B59.9B32.5B
Gross Profit32.7B32.5B35.1B41.9B43.9B46.1B
Other Operating Expenses34.6B39.5B35.5B41.0B56.9B59.7B
Operating Income9.2B5.4B10.6B14.7B3.0B2.8B
Ebit9.2B5.4B10.6B14.7B3.0B5.4B
Ebitda12.9B9.1B13.9B18.6B6.9B8.2B
Cost Of Revenue14.1B15.5B13.6B17.4B16.0B11.7B
Total Operating Expenses20.5B24.0B21.9B23.6B40.9B43.0B
Income Before Tax11.5B8.8B13.9B16.4B1.9B1.8B
Total Other Income Expense Net2.2B3.4B3.2B1.7B(1.1B)(1.0B)
Net Income9.8B7.1B13.0B14.5B365M346.8M
Income Tax Expense1.7B1.7B1.5B1.9B1.5B2.0B
Research Development9.9B13.6B12.2B13.5B30.5B32.1B
Selling General Administrative8.7B8.7B7.6B7.8B10.4B8.9B
Net Income Applicable To Common Shares9.8B7.1B13.0B14.5B16.7B17.5B
Minority Interest(66M)15M691M(7M)(13M)(12.4M)
Net Income From Continuing Ops9.8B7.1B12.4B14.5B4.6B8.0B
Non Recurring638M578M661M337M303.3M288.1M
Non Operating Income Net Other(139M)886M1.3B(1.5B)(1.4B)(1.3B)
Tax Provision1.7B1.7B1.5B1.9B2.8B2.2B
Interest Income274M59M1.9B1.3B390M732.6M
Net Interest Income(619M)(772M)(770M)(805M)(681M)(715.1M)
Reconciled Depreciation3.7B3.6B3.2B3.9B3.8B3.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.453
Dividend Share
2.92
Earnings Share
0.14
Revenue Per Share
23.695
Quarterly Revenue Growth
0.058
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.